We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
77 hedge funds and large institutions have $45.8M invested in Cardiff Oncology in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,335% more call options, than puts
Call options by funds: $4.67M | Put options by funds: $325K
483% more capital invested
Capital invested by funds: $7.86M → $45.8M (+$38M)
367% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 6
70% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 10
40% more funds holding
Funds holding: 55 → 77 (+22)
7.36% more ownership
Funds ownership: 11.88% → 19.25% (+7.4%)
Holders
77
Holders Change
+22
Holders Change %
+40%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
17
Reduced
10
Closed
6
Calls
$4.67M
Puts
$325K
Net Calls
+$4.34M
Net Calls Change
+$4.33M
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.82M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$1.15M |
| 3 |
Goldman Sachs
New York
|
+$760K |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$672K |
| 5 |
BC
BIT Capital
Berlin,
Germany
|
+$628K |
Top Sellers
| 1 |
BlackRock
New York
|
-$104K |
| 2 |
Renaissance Technologies
New York
|
-$80.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$73.8K |
| 4 |
EP
Elkhorn Partners
Omaha,
Nebraska
|
-$70.4K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$49.5K |
